HR 354 · 108th Congress · Taxation

North American Prescription Price Equity Act of 2003

Introduced 2003-01-27· Sponsored by Rep. Duncan, John J., Jr. [R-TN-2]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the House Committee on Ways and Means.(2003-01-27)

Plain Language Summary

[AI summary unavailable — showing source text] North American Prescription Price Equity Act of 2003 - Amends the Internal Revenue Code to allow drug manufacturers a limited tax credit if they certify that the wholesale price of a drug in the United States market is not greater than its wholesale price in the Canadian or Mexican market.…

Summarized by Claude AI · Non-partisan · For informational purposes only